Pamidronate--a promising new candidate for the management of spondyloarthropathy.
No Thumbnail Available
Date
2005-04-07
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Bisphosphonate group of agents are known for their anti-bone resorptive properties. However, recently their anti-inflammatory and anti-arthritis properties have come to light. Clinical trials of their use in spondyloarthropathy are showing promising results, especially in patients with shorter disease duration. The adverse event profile is mainly limited to postinfusion arthralgia, myalgia and fever. The concept of pamidronate in spondyloarthropathy management should be evaluated further in light of these clinical studies and could have a major impact on our resource-restricted setting.
Description
27 references.
Keywords
Citation
Akerkar SM, Bichile LS. Pamidronate--a promising new candidate for the management of spondyloarthropathy. Indian Journal of Medical Sciences. 2005 Apr; 59(4): 165-70